Skip to content

Clinical trials

Completed Phase 3 Panuveitis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Panuveitis Phase: Phase 3 Status: Completed Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20041
20073
20091
20152
20171

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Lux Biosciences, Inc.3
Clearside Biomedical, Inc.2
Sirion Therapeutics, Inc.2
EyePoint Pharmaceuticals, Inc.1
Novartis Pharmaceuticals1
University Hospital Tuebingen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Panuveitis10
Uveitis7
Uveitis, Posterior7
Uveitis, Intermediate6
Uveitis, Anterior4
Behcet Syndrome2
Inflammation1
Retinal Vasculitis1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.